134 related articles for article (PubMed ID: 3750374)
1. Clinical pharmacokinetics of carbamazepine and its epoxy and hydroxy metabolites in humans after an overdose.
Vree TB; Janssen TJ; Hekster YA; Termond EF; van de Dries AC; Wijnands WJ
Ther Drug Monit; 1986; 8(3):297-304. PubMed ID: 3750374
[TBL] [Abstract][Full Text] [Related]
2. Carbamazepine-10,11-diol steady-state serum levels and renal excretion during carbamazepine therapy in adults and children.
Bourgeois BF; Wad N
Ther Drug Monit; 1984; 6(3):259-65. PubMed ID: 6506133
[TBL] [Abstract][Full Text] [Related]
3. Single-dose kinetics and metabolism of carbamazepine-10,11-epoxide.
Tomson T; Tybring G; Bertilsson L
Clin Pharmacol Ther; 1983 Jan; 33(1):58-65. PubMed ID: 6848300
[TBL] [Abstract][Full Text] [Related]
4. Early stage autoinduction of carbamazepine metabolism in humans.
Bernus I; Dickinson RG; Hooper WD; Eadie MJ
Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
[TBL] [Abstract][Full Text] [Related]
5. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
Eichelbaum M; Tomson T; Tybring G; Bertilsson L
Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
[TBL] [Abstract][Full Text] [Related]
6. Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.
Kudriakova TB; Sirota LA; Rozova GI; Gorkov VA
Br J Clin Pharmacol; 1992 Jun; 33(6):611-5. PubMed ID: 1389933
[TBL] [Abstract][Full Text] [Related]
7. Single-dose kinetics of an enteric-coated formulation of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
Spina E; Tomson T; Svensson JO; Faigle JW; Bertilsson L
Ther Drug Monit; 1988; 10(4):382-5. PubMed ID: 3201523
[TBL] [Abstract][Full Text] [Related]
8. Daily variations in steady-state plasma concentrations of carbamazepine and its metabolites in epileptic children.
Hartley R; Forsythe WI; McLain B; Ng PC; Lucock MD
Clin Pharmacokinet; 1991 Mar; 20(3):237-46. PubMed ID: 2025982
[TBL] [Abstract][Full Text] [Related]
9. Charcoal hemoperfusion in the treatment of two cases of acute carbamazepine poisoning.
de Groot G; van Heijst AN; Maes RA
J Toxicol Clin Toxicol; 1984; 22(4):349-62. PubMed ID: 6527398
[TBL] [Abstract][Full Text] [Related]
10. Carbamazepine and carbamazepine-10,11-epoxide clearance measurements during continuous venovenous hemofiltration in a massive overdose.
Smollin CG; Petrie MS; Kearney T
Clin Toxicol (Phila); 2016 Jun; 54(5):424-7. PubMed ID: 26942940
[TBL] [Abstract][Full Text] [Related]
11. Carbamazepine and carbamazepine-10,11-epoxide pharmacokinetics in an overdose patient.
Patsalos PN; Krishna S; Elyas AA; Lascelles PT
Hum Toxicol; 1987 May; 6(3):241-4. PubMed ID: 3596609
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
[TBL] [Abstract][Full Text] [Related]
13. Serum concentrations of carbamazepine and its epoxide and diol metabolites in epileptic patients: the influence of dose and comedication.
Rambeck B; May T; Juergens U
Ther Drug Monit; 1987 Sep; 9(3):298-303. PubMed ID: 3672573
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of carbamazepine and its 10,11-epoxide metabolite in children.
Rane A; Höjer B; Wilson JT
Clin Pharmacol Ther; 1976 Mar; 19(3):276-83. PubMed ID: 1261166
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing plasma level/dose ratios of carbamazepine and its major metabolites in epileptic children.
Hartley R; Lucock MD; Ng PC; Forsythe WI; McLain B; Bowmer CJ
Ther Drug Monit; 1990 Sep; 12(5):438-44. PubMed ID: 2293405
[TBL] [Abstract][Full Text] [Related]
16. High-performance liquid chromatographic determination of carbamazepine and metabolites in human hair.
Saris LA; Brekelmans GJ; van der Linden GJ; Rademaker RV; Edelbroek PM
J Chromatogr B Biomed Sci Appl; 1997 Apr; 691(2):409-15. PubMed ID: 9174278
[TBL] [Abstract][Full Text] [Related]
17. The 10,11-epoxide-10,11-diol pathway of carbamazepine in early pregnancy in maternal serum, urine, and amniotic fluid: effect of dose, comedication, and relation to outcome of pregnancy.
Omtzigt JG; Los FJ; Meijer JW; Lindhout D
Ther Drug Monit; 1993 Feb; 15(1):1-10. PubMed ID: 8451773
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation.
Bertilsson L; Tomson T; Tybring G
J Clin Pharmacol; 1986; 26(6):459-62. PubMed ID: 3734137
[TBL] [Abstract][Full Text] [Related]
19. [Carbamazepine "CR"--clinical picture of intoxication: the kinetics of extracorporeal elimination].
Kołacński Z; Winnicka R; Lopaciński B; Kołacińska M
Przegl Lek; 2005; 62(6):482-5. PubMed ID: 16225101
[TBL] [Abstract][Full Text] [Related]
20. Haplotype structures of EPHX1 and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
Nakajima Y; Saito Y; Shiseki K; Fukushima-Uesaka H; Hasegawa R; Ozawa S; Sugai K; Katoh M; Saitoh O; Ohnuma T; Kawai M; Ohtsuki T; Suzuki C; Minami N; Kimura H; Goto Y; Kamatani N; Kaniwa N; Sawada J
Eur J Clin Pharmacol; 2005 Mar; 61(1):25-34. PubMed ID: 15692831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
